Hormonaly, Inc. is a clinical AI infrastructure company that builds evidence-grounded medical intelligence for healthcare software teams. Its flagship product, Helix API, is an enterprise REST API that returns GRADE-rated clinical evidence synthesis with citations verified against PubMed, letting developers embed defensible clinical reasoning into EHRs, telehealth platforms, pharmacy systems, and clinical decision support tools. Hormonaly trains and operates its own clinical models, including Hormonaly-1, a fine-tune of NVIDIA's Llama-3.3-Nemotron-Super-49B developed through the NVIDIA Inception and Innovation Lab programs, and maintains a proprietary GRADE-rated evidence corpus spanning endocrinology, metabolic health, peptide therapeutics, and longevity medicine. The company was founded by Dr. Fady Hannah-Shmouni, MD FRCPC, a board-certified endocrinologist and geneticist. Teams use Hormonaly to add citation-backed clinical AI to a product without building an in-house evidence pipeline, with HIPAA-conscious architecture and both hosted and customer-owned model weight deployment.